These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37030570)

  • 1. Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay.
    Vazquez C; Gutierrez-Acevedo MN; Barbero S; Notari LDC; Agozino M; Fernandez JL; Anders MM; Grigera NL; Antinucci F; Orozco-Ganem ONF; Murga MD; Perez MD; Palazzo AG; Rejtman LM; Duarte IG; Vorobioff JD; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Borzi SM; Stieben TE; Masola AC; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz PM; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Calzetta PA; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH; Marciano S
    Ann Hepatol; 2023; 28(4):101097. PubMed ID: 37030570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection in cirrhosis: A prospective study.
    Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
    Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards evidence-based empiric antibiotic recommendations for spontaneous infections in patients with cirrhosis.
    Dirchwolf M; Gomez Perdiguero G; Cairo F; Vazquez C; Notari L; Murga MD; Elizondo M; Bessone F; Agozino M; Brutti J; Zerega AR; Pages J; Stieben TE; Calzetta P; Arufe D; González Ballerga E; Giunta D; Smud A; Osso Sanchez B; Navarro L; Palazzo A; Valverde M; Gadano A; Marciano S
    Dig Liver Dis; 2024 Aug; ():. PubMed ID: 39107169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany.
    Kremer WM; Gairing SJ; Kaps L; Ismail E; Kalampoka V; Hilscher M; Michel M; Siegel E; Schattenberg JM; Galle PR; Sprinzl MF; Wörns MA; Nagel M; Labenz C
    Ann Hepatol; 2022; 27(5):100719. PubMed ID: 35460883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.
    Aguilar-Duran S; Horcajada JP; Sorlí L; Montero M; Salvadó M; Grau S; Gómez J; Knobel H
    J Infect; 2012 May; 64(5):478-83. PubMed ID: 22285591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
    Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
    J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
    Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
    Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
    Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
    Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
    Marciano S; Gutierrez-Acevedo MN; Barbero S; Del C Notari L; Agozino M; Fernandez JL; Anders MM; Grigera N; Antinucci F; Orozco Ganem OF; Murga MD; Perez D; Palazzo A; Martinez Rejtman L; Duarte IG; Vorobioff J; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Bosia JD; Borzi SM; Stieben TE; Masola A; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz P; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Bellizzi C; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):481-491. PubMed ID: 36820931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany.
    Hillert A; Schultalbers M; Tergast TL; Vonberg RP; Rademacher J; Wedemeyer H; Cornberg M; Ziesing S; Maasoumy B; Höner Zu Siederdissen C
    BMC Gastroenterol; 2021 Jul; 21(1):296. PubMed ID: 34284732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
    Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
    World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
    Milovanovic T; Dumic I; Veličkovic J; Lalosevic MS; Nikolic V; Palibrk I
    BMC Infect Dis; 2019 Feb; 19(1):141. PubMed ID: 30755176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
    PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
    Bader MS; Loeb M; Leto D; Brooks AA
    Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.